Page last updated: 2024-11-02

pantoprazole and Eye Cancer, Retinoblastoma

pantoprazole has been researched along with Eye Cancer, Retinoblastoma in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pascual-Pasto, G1
Olaciregui, NG1
Opezzo, JAW1
Castillo-Ecija, H1
Cuadrado-Vilanova, M1
Paco, S1
Rivero, EM1
Vila-Ubach, M1
Restrepo-Perdomo, CA1
Torrebadell, M1
Suñol, M1
Schaiquevich, P1
Mora, J1
Bramuglia, GF1
Chantada, GL1
Carcaboso, AM1

Other Studies

1 other study available for pantoprazole and Eye Cancer, Retinoblastoma

ArticleYear
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
    Journal of controlled release : official journal of the Controlled Release Society, 2017, Oct-28, Volume: 264

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; ATP Binding Cassette Transporter, Subfamily B, Mem

2017